2021
DOI: 10.5114/pjp.2021.111770
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of EZH2 and ERRα in colorectal carcinoma: an immunohistochemical study

Abstract: The combined immunohistochemical evaluation of EZH2 (enhancer of zeste homolog 2) and ERRα (estrogen-related receptor α), in relation to clinicopathological prognostic factors and patients' outcome, has not been performed yet in colorectal carcinoma (CRC). In order to achieve this aim, 120 samples were extracted; 60 cases of CRC; and 60 samples from normal colonic tissue. Our study showed that 63.3% and 38.3% of CRC cases reveal high EZH2 and high ERRα nuclear expression, respectively. 6.6% and 8.3% of normal … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
3
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(3 citation statements)
references
References 41 publications
0
3
0
Order By: Relevance
“…Recent evidence have reported the critical role of ERR in various metabolic diseases and cancer [ 309 , 311 ]. In line with this, studies have also evaluated the role of ERR in regulating various molecules and processes involved in CRC [ 96 , 97 , 99 , 312 ].…”
Section: Nuclear Receptors In Colorectal Cancermentioning
confidence: 99%
See 2 more Smart Citations
“…Recent evidence have reported the critical role of ERR in various metabolic diseases and cancer [ 309 , 311 ]. In line with this, studies have also evaluated the role of ERR in regulating various molecules and processes involved in CRC [ 96 , 97 , 99 , 312 ].…”
Section: Nuclear Receptors In Colorectal Cancermentioning
confidence: 99%
“…The expression of ERR α was found to be upregulated in CRC cells and tissues [ 96 , 97 , 99 , 312 ]. In addition, ERR α overexpression was associated with shorter OS and progression-free survival (PFS) and correlated with advanced stage and higher tumor grade [ 99 ].…”
Section: Nuclear Receptors In Colorectal Cancermentioning
confidence: 99%
See 1 more Smart Citation